268 related articles for article (PubMed ID: 15146368)
1. Applicability of the SHBG androgen sensitivity test in the differential diagnosis of 46,XY gonadal dysgenesis, true hermaphroditism, and androgen insensitivity syndrome.
Krause A; Sinnecker GH; Hiort O; Thamm B; Hoepffner W
Exp Clin Endocrinol Diabetes; 2004 May; 112(5):236-40. PubMed ID: 15146368
[TBL] [Abstract][Full Text] [Related]
2. [A laboratory test for the detection of androgen resistance using sex hormone-binding globulin].
Hampl R; Stárka L; Snajderová M; Lachman M; Kalvachová B
Vnitr Lek; 1992 Sep; 38(9):879-86. PubMed ID: 1481386
[TBL] [Abstract][Full Text] [Related]
3. Sex hormone-binding globulin response to the anabolic steroid stanozolol: evidence for its suitability as a biological androgen sensitivity test.
Sinnecker G; Köhler S
J Clin Endocrinol Metab; 1989 Jun; 68(6):1195-200. PubMed ID: 2723028
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of SHBG test for disclosure of insensitivity to androgens.
Hampl R; Stárka L; Kalvachová B; Lachman M; Snajderová M; Lisá L; Zapletalová J; Hill M
Endocr Regul; 1993 Jun; 27(2):65-70. PubMed ID: 8003712
[TBL] [Abstract][Full Text] [Related]
5. Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene. German Collaborative Intersex Study Group.
Sinnecker GH; Hiort O; Nitsche EM; Holterhus PM; Kruse K
Eur J Pediatr; 1997 Jan; 156(1):7-14. PubMed ID: 9007482
[TBL] [Abstract][Full Text] [Related]
6. Prostate screening in patients with 46,XY disorders of sex development--is it necessary?
Salmasi AH; Wisniewski AB; Novak TE; Gearhart JP; Migeon CJ; Lakshmanan Y
J Urol; 2008 Oct; 180(4):1422-5; discussion 1425-6. PubMed ID: 18710761
[TBL] [Abstract][Full Text] [Related]
7. Detection of Y-chromosome in gonadal tumours using fluorescence in situ hybridization: diagnostic value in intersex conditions including older patients with clinically unsuspected androgen insensitivity syndrome.
Stewart CJ; Baker E; Beaton C; Crook M; Peverall J; Wallace S
Histopathology; 2008 Jan; 52(2):175-82. PubMed ID: 18184266
[TBL] [Abstract][Full Text] [Related]
8. [Intersexuality: gonadal dysgenesis and testicular feminization].
Schweikert HU
Gynakologe; 1995 Feb; 28(1):17-26. PubMed ID: 7705711
[No Abstract] [Full Text] [Related]
9. Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age.
Elmlinger MW; Kühnel W; Wormstall H; Döller PC
Clin Lab; 2005; 51(11-12):625-32. PubMed ID: 16329620
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel receptor mutation A-->T at exon 4 in complete androgen insensitivity syndrome and a carrier sibling via bidirectional polymorphism sequence analysis.
Sills ES; Sholes TE; Perloe M; Kaplan CR; Davis JG; Tucker MJ
Int J Mol Med; 2002 Jan; 9(1):45-8. PubMed ID: 11744994
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and management of patients with sex differentiation disorders: experience at the Unit of Medical Genetics of the University of Zulia, Maracaibo, Venezuela].
Alvarez-Nava F; González-Ferrer S; Soto M
Invest Clin; 1998 Dec; 39(4):273-92. PubMed ID: 9927802
[TBL] [Abstract][Full Text] [Related]
12. Differentiating Swyer syndrome and complete androgen insensitivity syndrome: a diagnostic dilemma.
Nunes E; Rodrigues C; Geraldes F; Aguas F
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):e67-8. PubMed ID: 24119655
[TBL] [Abstract][Full Text] [Related]
13. [Incomplete androgen insensitivity].
Luczay A; Sólyom J; Hiort O; Szabó E; Dobos M; Jenovári Z; Fekete G
Orv Hetil; 2006 Sep; 147(37):1805-7. PubMed ID: 17131800
[TBL] [Abstract][Full Text] [Related]
14. [Androgen insensitivity].
Stárka L; Hampl R
Cas Lek Cesk; 1994 Jun; 133(13):387-90. PubMed ID: 8062328
[TBL] [Abstract][Full Text] [Related]
15. Plasma sex hormone-binding globulin rather than corticosteroid-binding globulin is a marker of insulin resistance in obese adult males.
Lewis JG; Shand BI; Elder PA; Scott RS
Diabetes Obes Metab; 2004 Jul; 6(4):259-63. PubMed ID: 15171749
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the AR and SRD5A2 genes in patients with 46,XY disorders of sex development.
Choi JH; Kim GH; Seo EJ; Kim KS; Kim SH; Yoo HW
J Pediatr Endocrinol Metab; 2008 Jun; 21(6):545-53. PubMed ID: 18717241
[TBL] [Abstract][Full Text] [Related]
17. Novel androgen receptor gene mutations in Australian patients with complete androgen insensitivity syndrome.
MacLean HE; Ball EM; Rekaris G; Warne GL; Zajac JD
Hum Mutat; 2004 Mar; 23(3):287. PubMed ID: 14974091
[TBL] [Abstract][Full Text] [Related]
18. 46,XY disorders of sex development--the undermasculinised male with disorders of androgen action.
Werner R; Grötsch H; Hiort O
Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):263-77. PubMed ID: 20541151
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro.
Holterhus PM; Werner R; Struve D; Hauffa BP; Schroeder C; Hiort O
Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):457-63. PubMed ID: 16151980
[TBL] [Abstract][Full Text] [Related]
20. The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome.
Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
Hum Reprod; 2008 Mar; 23(3):693-8. PubMed ID: 18192296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
